Consequently, in mice bearing melanoma xenografts, PD-1/SIRPα nanovesicles substantially promoted the infiltration of CD8+ T cells and the polarization of M1-type tumor-associated macrophages (TAMs), collectively enhancing therapeutic outcomes. The gene discussed is SIRPA; the disease is melanoma.